Prognosis
Pfizer Plant Boosting Vaccines Has Repeat Quality Offenses
- Kansas factory cited by FDA last year after past missteps
- Pfizer filling vaccine vials and packing for shipment at plant
This article is for subscribers only.
The factory that Pfizer Inc. plans to use to boost production of its Covid-19 vaccine for the massive U.S. inoculation effort was cited by federal inspectors last year for repeated quality-control violations.
Food and Drug Administration inspectors visited the McPherson, Kansas, plant at the end of 2019 into January 2020, according to an inspection report obtained by Bloomberg via a Freedom of Information request. They found the drug giant released medications for sale after failing to thoroughly review quality issues that arose in routine testing, the report shows.